Anabolic steroids and cardiovascular risk
- PMID: 22229259
- DOI: 10.2165/11598060-000000000-00000
Anabolic steroids and cardiovascular risk
Abstract
Recent reports from needle exchange programmes and other public health initiatives have suggested growing use of anabolic steroids (AS) in the UK and other countries. Data indicate that AS use is not confined to body-builders or high-level sportsmen. Use has spread to professionals working in emergency services, casual fitness enthusiasts and subelite sportsmen and women. Although the precise health consequences of AS use is largely undefined, AS use represents a growing public health concern. Data regarding the consequences of AS use on cardiovascular health are limited to case studies and a modest number of small cohort studies. Numerous case studies have linked AS use with a variety of cardiovascular disease (CVD) events or endpoints, including myocardial infarction, stroke and death. Large-scale epidemiological studies to support these links are absent. Consequently, the impact of AS use upon known CVD risk factors has been studied in relatively small, case-series studies. Data relating AS use to elevated blood pressure, altered lipid profiles and ECG abnormalities have been reported, but are often limited in scope, and other studies have often produced equivocal outcomes. The use of AS has been linked to the appearance of concentric left ventricular hypertrophy as well as endothelial dysfunction but the data again remains controversial. The mechanisms responsible for the negative effect of AS on cardiovascular health are poorly understood, especially in humans. Possibilities include direct effects on myocytes and endothelial cells, reduced intracellular Ca2+ levels, increased release of apoptogenic factors, as well as increased collagen crosslinks between myocytes. New data relating AS use to cardiovascular health risks are emerging, as novel technologies are developed (especially in non-invasive imaging) that can assess physiological structure and function. Continued efforts to fully document the cardiovascular health consequences of AS use is important to provide a clear, accurate, public health message to the many groups now using AS for performance and image enhancement.
Similar articles
-
Androgenic anabolic steroid abuse and the cardiovascular system.Handb Exp Pharmacol. 2010;(195):411-57. doi: 10.1007/978-3-540-79088-4_18. Handb Exp Pharmacol. 2010. PMID: 20020375 Review.
-
[Cardiovascular side effects of anabolic-androgenic steroids].Herz. 2006 Sep;31(6):566-73. doi: 10.1007/s00059-006-2856-0. Herz. 2006. PMID: 17036188 German.
-
Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging.Eur J Clin Invest. 2012 Jul;42(7):795-803. doi: 10.1111/j.1365-2362.2011.02642.x. Epub 2012 Feb 2. Eur J Clin Invest. 2012. PMID: 22299602 Review.
-
Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.Eur J Clin Invest. 2006 Jul;36(7):483-8. doi: 10.1111/j.1365-2362.2006.01667.x. Eur J Clin Invest. 2006. PMID: 16796605
-
Steroid use and long-term health risks in former athletes.Sports Med. 2002;32(2):83-94. doi: 10.2165/00007256-200232020-00001. Sports Med. 2002. PMID: 11817994 Review.
Cited by
-
Testosterone and secondary hypertension: new pieces to the puzzle.Hypertension. 2012 Jun;59(6):1101-3. doi: 10.1161/HYPERTENSIONAHA.112.195149. Epub 2012 May 7. Hypertension. 2012. PMID: 22566501 Free PMC article. No abstract available.
-
Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment.Asian J Androl. 2014 Mar-Apr;16(2):192-202. doi: 10.4103/1008-682X.122336. Asian J Androl. 2014. PMID: 24407185 Free PMC article. Review.
-
The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment.Subst Abuse. 2020 Feb 18;14:1178221820904150. doi: 10.1177/1178221820904150. eCollection 2020. Subst Abuse. 2020. PMID: 32127749 Free PMC article.
-
Myocardial scar detected by cardiovascular magnetic resonance in a competitive bodybuilder with longstanding abuse of anabolic steroids.Asian J Sports Med. 2014 Dec;5(4):e24058. doi: 10.5812/asjsm.24058. Epub 2014 Nov 10. Asian J Sports Med. 2014. PMID: 25741416 Free PMC article.
-
Ventricular structure, function, and focal fibrosis in anabolic steroid users: a CMR study.Eur J Appl Physiol. 2014 May;114(5):921-8. doi: 10.1007/s00421-014-2820-2. Epub 2014 Jan 28. Eur J Appl Physiol. 2014. PMID: 24463601
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous